Summary of Significant Accounting Policies - Additional Information (Detail)			1 Months Ended	12 Months Ended
	Aug. 09, 2023 USD ($) shares	Jul. 09, 2023 USD ($) yr $ / shares shares	Aug. 31, 2024 USD ($) yr	Dec. 31, 2024 USD ($) Segment $ / shares	Dec. 31, 2023 USD ($) yr
Number of operating segments | Segment				1
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]				Chief Executive Officer [Member]
Cash in excess of federally insured limits				$ 0
Cash equivalents				25,374	$ 30,000
Loss on the write-down				4,754,357
Deferred offering costs capitalized				86,314
Reserve for inventory obsolescense				0	0
Deferred offering costs				86,314
Goodwill or intangible asset impairment charges recognized				0	0
Change in the fair value of the earnout liability				$ 13,482,292
Termination fee payable per share | $ / shares		$ 0.5
Temporary equity, redemption price per share | $ / shares		$ 10.28		$ 10.28
Services accounted for consideration payable and reduction of transaction price					440,784
Revenue, performance obligation, description of timing				The Company has elected to apply the significant financing practical expedient, as allowed under ASC 606. As a result, the Company does not adjust the promised amount of consideration in a customer contract for the effects of a significant financing component when the period of time between when the Company transfers a promised good or service to a customer and when the customer pays for the good or service will be one year or less.
Revenue, performance obligation, description of payment terms				The Company has standard payment terms that generally require payment within approximately 30-120 days.
Unrecognized tax benefits				$ 0	0
Accrued for interest and penalties				0	0
Sales and marketing expenses				$ 189,323
Severance unpaid					452,579
AxoBio [Member]
Sales and marketing expenses					$ 6,829,520
Customer Contracts [Member]
Finite-lived intangible assets, amortization period				20 years
Trade Names [Member]
Finite-lived intangible assets, amortization period				7 years
Intellectual Property [Member]
Finite-lived intangible assets, amortization period				7 years
Patents [Member]
Finite-lived intangible assets, amortization period				16 years
Meteora [Member]
Proceeds from temporary equity acquisitions equivalent to amount remitted under otc equity prepaid forward transaction		$ 17,535,632
Forward Purchase Agreement [Member] | Level 3 [Member]
Derivative Asset, Valuation Technique [Extensible Enumeration]		us-gaap:ValuationTechniqueOptionPricingModelMember
Forward Purchase Agreement [Member] | Level 3 [Member] | Share Price [Member]
Derivative Asset, Measurement Input			1.1		3.81
Forward Purchase Agreement [Member] | Level 3 [Member] | Share Price [Member] | Monte Carlo model [Member]
Derivative Asset, Measurement Input			1.1
Forward Purchase Agreement [Member] | Level 3 [Member] | Termination Fee [Member]
Derivative Asset, Measurement Input		0.5	0.5		0.5
Forward Purchase Agreement [Member] | Level 3 [Member] | Debt Rate [Member]
Derivative Asset, Measurement Input		14.35	14.7		12.95
Forward Purchase Agreement [Member] | Level 3 [Member] | Debt Rate [Member] | Monte Carlo model [Member]
Derivative Asset, Measurement Input			7.33
Forward Purchase Agreement [Member] | Level 3 [Member] | Expected Term (years) [Member]
Derivative Asset, Measurement Input | yr		1			0.54
Forward Purchase Agreement [Member] | Level 3 [Member] | Expected Term (years) [Member] | Monte Carlo model [Member]
Derivative Asset, Measurement Input | yr			4.06
Forward Purchase Agreement [Member] | Level 3 [Member] | Volatility Factor [Member] | Monte Carlo model [Member]
Derivative Asset, Measurement Input			85.9
Series A Convertible Voting Preferred Stock [Member]
Stock issued during period, shares, new issues | shares	4,243
Common Class A [Member] | Forward Purchase Agreement [Member] | Meteora [Member]
Stock issued during period, shares, new issues | shares		1,705,959
Daily VWAP price			0.75
Loss on contract termination			$ 254,664
Minimum [Member]
Finite-lived intangible assets, amortization period				7 years
Revenue, remaining performance obligation, expected timing of satisfaction, period				30 days
Maximum [Member]
Finite-lived intangible assets, amortization period				20 years
Revenue, remaining performance obligation, expected timing of satisfaction, period				120 days
Maximum [Member] | Common Stock [Member]
Performance-based earn-outs liability	$ 66,000,000
Maximum [Member] | Cash Earnout [Member]
Performance-based earn-outs liability	9,000,000
Maximum [Member] | Cash Earnout [Member] | AxoBio [Member]
Performance-based earn-outs liability	$ 9,000,000
Equipment [Member] | Minimum [Member]
Property and equipment estimated useful lives				5 years
Equipment [Member] | Maximum [Member]
Property and equipment estimated useful lives				7 years
Leasehold Improvements [Member]
Property and equipment estimated useful lives				10 years
Furniture and Fixtures [Member]
Property and equipment estimated useful lives				7 years
ASU 2016-13 [Member]
Change in Accounting Principle, Accounting Standards Update, Adopted				true
Change in Accounting Principle, Accounting Standards Update, Adoption Date				Jan. 01, 2023
Change in Accounting Principle, Accounting Standards Update, Immaterial Effect				true
ASU 2020-06 [Member]
Change in Accounting Principle, Accounting Standards Update, Adopted				true
Change in Accounting Principle, Accounting Standards Update, Adoption Date				Jan. 01, 2024
Change in Accounting Principle, Accounting Standards Update, Immaterial Effect				true
ASU 2023-07 [Member]
Change in Accounting Principle, Accounting Standards Update, Adopted				true
Change in Accounting Principle, Accounting Standards Update, Adoption Date				Jan. 01, 2024
Change in Accounting Principle, Accounting Standards Update, Immaterial Effect				true